1. Expanding Accessibility to CD19-CAR T Cells: Commercializing a “Boutique” Therapy 
Premal Lulla, Carlos A. Ramos 
Molecular Therapy 
Volume 25, Issue 1, Pages 8-9 (January 2017)
DOI: /j.ymthe
Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

2. Figure 1 Centralized CD19 CAR T Cell Manufacturing
CD19 CAR T cell products are manufactured centrally from shipped patient apheresis units. Clinical grade products are then cryo-shipped back to the respective patients’ institutions for infusion.
Molecular Therapy  , 8-9DOI: ( /j.ymthe )
Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions